Related Experiment Videos

Bronchiectasis: the consequence of late diagnosis in chronic respiratory symptoms

Deniz Doğru1, Afssane Nik-Ain, Nural Kiper

  • 1Department of Pediatrics, Pulmonary Medicine Unit, Hacettepe University, Ankara, Turkey. ddogru@hacettepe.edu

Journal of Tropical Pediatrics
|May 14, 2005
PubMed

Insights

This study identified causes of non-cystic fibrosis (CF) bronchiectasis in 204 children, finding infection as the most common cause. Early diagnosis and treatment are crucial for improving outcomes in pediatric bronchiectasis.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Bronchiectasis remains prevalent in developing nations, including Turkey.
  • Non-cystic fibrosis (CF) bronchiectasis in children requires specific investigation into risk factors and management.

Purpose of the Study:

  • To determine the incidence of non-CF bronchiectasis in children.
  • To identify associated risk factors and etiological causes.
  • To highlight the importance of early diagnosis and treatment.

Main Methods:

  • Retrospective review of 204 children diagnosed with bronchiectasis (excluding CF).
  • Diagnostic procedures included imaging (radiography, CT), bronchoscopy, and biopsies.
  • Laboratory tests encompassed immunoglobulin levels, alpha-1 antitrypsin, and eosinophil counts.

Main Results:

  • The most frequent symptoms were cough, sputum production, and dyspnea.
  • Left lower lobe involvement was most common.
  • Infections were the leading identified cause (49% undetermined), followed by asthma, primary ciliary dyskinesia, immune deficiencies, and foreign body aspiration.

Conclusions:

  • Preventive measures like vaccination and improved nutrition can reduce pediatric bronchiectasis incidence in developing countries.
  • Prompt diagnosis and intervention are essential to mitigate irreversible complications and enhance survival rates for children with bronchiectasis.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.